Optimized 2D-RT for Prostate Cancer
2018年3月12日 更新者:Alessio Giuseppe Morganti、IRCCS Azienda Ospedaliero-Universitaria di Bologna
Definition of Fields Margins for Optimized 2D Radiotherapy of Prostate Carcinoma
Prostate cancer (CAP) is one of the most common malignancies in men, both in Western countries and developing countries.
Radiation therapy (RT) is an important therapeutic option.
New technologies (3D, IMRT, IGRT, VMAT) have been introduced in the last decades, with a progressive improvement of clinical outcome.
However, in many countries the only treatment option is the traditional 2D technique based on standard simulation.
The indications for field definition in this treatment are still based on expert's opinions.
The aim of this analysis is to propose new indications for 2D fields definition based on three-dimensional simulation in a population of patients with CAP.
Twenty patients with CAP consecutively treated with RT in our center were identified.
Patients underwent CT-simulation in supine position.
Pelvic MRI images were fused with CT-simulation images.
In this way, delineation of the prostate and seminal vesicles was performed on MRI images.
Clinical Target Volume definition (CTV) was performed according to EORTC guidelines simulating 4 different categories: low-risk CAP, intermediate-risk CAP, high-risk CAP without involvement of the seminal vesicles, and high-risk CAP with involvement of seminal vesicles.
The Planning Target Volume (PTV) was defined by adding a margin of 10 mm to the CTV in all directions.
For each patient, 8 treatment plans were calculated.
In particular, for each of the 4 categories of risk, 2 treatment plans were calculated by using a cobalt source or 10 MV photons.
Treatment plans were calculated using the box technique.
Progressive optimization was realized with an iterative procedure by evaluating the three-dimensional dose distribution.
Once the final plan was achieved (respecting the PTV constraint: D98 > 95%), distances of the fields edges from a set of reference points were measured.
研究概览
研究类型
介入性
注册 (实际的)
20
阶段
- 不适用
参与标准
研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
18年 至 79年 (成人、年长者)
接受健康志愿者
不
有资格学习的性别
男性
描述
Inclusion Criteria:
- > 18 years
- clinical T stage: cT2b, cT2c, cT3a, cT3b
- informed consent
- MRI of the pelvis
Exclusion Criteria:
- > 79 years
- prior surgery treatment for prostate cancer
- prior pelvic radiotherapy
- genetic syndromes of hyper-radio-sensitivity
- chronic infiammatory bowel disease
学习计划
本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:不适用
- 介入模型:单组作业
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:2D radiotherapy
Patients with prostate cancer were treated with 2D-radiotherapy
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
new indications for 2D fields definition
大体时间:through study completion, up to 10 months
|
Twenty patients with prostate cancer (CAP) were identified.
Pelvic MRI images were fused with CT-simulation images to delineate prostate and seminal vesicles on MRI images.
Clinical Target Volume definition (CTV) was performed according to EORTC guidelines simulating 4 different categories: low-risk CAP, intermediate-risk CAP, high-risk CAP with or without involvement of the seminal vesicles.
The Planning Target Volume (PTV) was defined by adding a margin of 10 mm to the CTV.
For each patient, 8 treatment plans were calculated using box tecnhique: 2 treatment plans for each risk category were calculated by using a cobalt source or 10 MV photons.
Progressive optimization was realized with an iterative procedure by evaluating the three-dimensional dose distribution.
Once the final plan was achieved (respecting the PTV constraint: D98 > 95%), distances of the fields edges from a set of reference points were measured.
|
through study completion, up to 10 months
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 研究主任:Alessio G Morganti, MD、Radiation Oncology Center, Department of Experimental, Diagnostic and Speciality Medicine-DIMES, Unversity of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (实际的)
2015年2月2日
初级完成 (实际的)
2015年12月18日
研究完成 (实际的)
2015年12月18日
研究注册日期
首次提交
2017年11月3日
首先提交符合 QC 标准的
2017年11月9日
首次发布 (实际的)
2017年11月13日
研究记录更新
最后更新发布 (实际的)
2018年3月13日
上次提交的符合 QC 标准的更新
2018年3月12日
最后验证
2018年3月1日
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.